Log in

NYSE:WX - WuXi PharmaTech (Cayman) Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
WuXi PharmaTech (Cayman) Inc is a pharmaceutical, biotechnology and medical device research and development (R&D) services company, with operations in China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to its customers. It conducts its operations in two segments: Laboratory services and Manufacturing services. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
WebN/A
Phone+86-21-50461111

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive WX News and Ratings via Email

Sign-up to receive the latest news and ratings for WX and its competitors with MarketBeat's FREE daily newsletter.


WuXi PharmaTech (Cayman) (NYSE:WX) Frequently Asked Questions

What is WuXi PharmaTech (Cayman)'s stock symbol?

WuXi PharmaTech (Cayman) trades on the New York Stock Exchange (NYSE) under the ticker symbol "WX."

Has WuXi PharmaTech (Cayman) been receiving favorable news coverage?

News stories about WX stock have been trending extremely negative this week, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. WuXi PharmaTech (Cayman) earned a news sentiment score of -4.5 on InfoTrie's scale. They also gave press coverage about the medical research company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for WuXi PharmaTech (Cayman).

What other stocks do shareholders of WuXi PharmaTech (Cayman) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other WuXi PharmaTech (Cayman) investors own include Baidu (BIDU), Himax Technologies (HIMX), Yelp (YELP), Celgene (CELG), Endocyte (ECYT), SolarCity (SCTY), Synaptics (SYNA), 3D Systems (DDD), Health Net (HNT) and VMware (VMW).

How can I contact WuXi PharmaTech (Cayman)?

WuXi PharmaTech (Cayman)'s mailing address is 288 Fute Zhong Road China (Shanghai) Pilot Free Trade Zone, SHANGHAI, SHA 200131, China. The medical research company can be reached via phone at +86-21-50461111.


MarketBeat Community Rating for WuXi PharmaTech (Cayman) (NYSE WX)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  215 (Vote Outperform)
Underperform Votes:  170 (Vote Underperform)
Total Votes:  385
MarketBeat's community ratings are surveys of what our community members think about WuXi PharmaTech (Cayman) and other stocks. Vote "Outperform" if you believe WX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/26/2020 by MarketBeat.com Staff

Featured Article: Most Volatile Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel